You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,097,061


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,097,061 protect, and when does it expire?

Patent 11,097,061 protects DEXYCU KIT and is included in one NDA.

This patent has eight patent family members in seven countries.

Summary for Patent: 11,097,061
Title:Systems, kits and methods for loading and delivering a small volume dose from a syringe
Abstract: A kit is disclosed for accurately loading a small volume dose of a medication within a syringe and for delivering the small volume dose of the medication at a treatment site. The kit generally includes a loading and delivery system in accordance herewith, a syringe, and a medication. The loading and delivery system includes a syringe delivery ring and a syringe loading guide, which may be used for example, to administer a small volume dose of a medication at the end of an ocular surgery.
Inventor(s): Gerlett; Cathy Ann (Klamath Falls, OR)
Assignee: ICON BIOSCIENCE, INC. (Watertown, MA)
Application Number:16/269,910
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device;
Patent landscape, scope, and claims:

United States Patent 11,097,061: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 11,097,061, titled "Systems, kits and methods for loading and delivering a small volume dose from a syringe," is a significant innovation in the field of medical device technology. This patent, assigned to ICON BIOSCIENCE, INC., addresses the need for precise and efficient delivery of small volume doses of medication, particularly in the context of ocular surgery.

Inventor and Assignee

The patent was invented by Cathy Ann Gerlett and is assigned to ICON BIOSCIENCE, INC., a company based in Watertown, MA. This assignment highlights the company's focus on developing advanced medical devices and delivery systems[1].

Abstract and Summary

The patent describes a kit designed for accurately loading and delivering small volume doses of medication using a syringe. The kit includes a loading and delivery system, a syringe, and the medication itself. Key components of the loading and delivery system are the syringe delivery ring and the syringe loading guide. These components facilitate the precise administration of medication, such as at the end of an ocular surgery[1].

Claims

The patent includes several claims that define the scope of the invention. These claims cover various aspects of the system, including:

  • The loading and delivery system
  • The syringe and its components
  • The method of loading and delivering the medication
  • The specific application in ocular surgery

Each claim is designed to ensure the patent's validity and protect the unique features of the invention[1].

Patent Family and Global Protection

The patent has eight patent family members in seven countries, including Australia, Canada, China, the European Patent Office, Israel, and others. This global protection ensures that the invention is safeguarded across multiple jurisdictions, preventing unauthorized use and replication[1].

Technical Details

The loading and delivery system is crucial for the accurate administration of small volume doses. The syringe delivery ring and syringe loading guide work in tandem to ensure that the medication is loaded precisely and delivered to the treatment site without error. This precision is particularly important in ocular surgery, where small volumes of medication can have significant therapeutic effects[1].

Market Impact

The invention has the potential to significantly impact the medical device market, especially in the field of ophthalmology. By providing a reliable and precise method for delivering small volume doses, this patent can enhance surgical outcomes and patient care. It also opens up opportunities for further innovation in drug delivery systems.

Competitive Landscape

In the competitive landscape of medical device patents, this invention stands out due to its specificity and practical application. Other patents in the field may focus on broader aspects of drug delivery, but the precision and focus on small volume doses set this patent apart. Companies like ICON BIOSCIENCE, INC. are at the forefront of this innovation, driving advancements in medical technology[1].

Legal and Regulatory Considerations

The patent is subject to the legal and regulatory frameworks governing medical devices and pharmaceuticals. The presumption of validity under 35 USC 282 means that each claim of the patent is presumed valid unless proven otherwise. This legal framework provides strong protection for the invention and its claims[5].

Global Patent System Integration

The global patent system, facilitated by tools like the Global Dossier and Common Citation Document (CCD), ensures that patent applications and granted patents are integrated across different jurisdictions. This integration helps in maintaining consistency and reducing duplication in patent searches and examinations[4].

Public Access and Search Tools

Public access to patent information is crucial for innovation and competition. Tools like the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) provide comprehensive resources for searching and analyzing patents. These tools enable researchers, inventors, and companies to understand the patent landscape and avoid potential infringement[4].

Economic and Research Implications

The Patent Claims Research Dataset by the USPTO provides detailed information on patent claims, which can be used to analyze the scope and impact of patents like 11,097,061. This dataset helps in understanding trends in patent scope and the economic implications of patent protection[3].

Expert Insights

Industry experts and legal practitioners often emphasize the importance of precise patent claims and the need for a robust patent system. For example, Andrei Iancu, former Undersecretary of Commerce for IP and Director of the USPTO, has highlighted the critical role of patents in driving innovation and economic growth[2].

"Patents are not just legal documents; they are instruments of innovation and economic growth." - Andrei Iancu[2]

Future Developments and Challenges

As medical technology continues to evolve, patents like 11,097,061 will play a crucial role in shaping the future of drug delivery systems. However, challenges such as the need for a small claims patent court, as discussed by the Administrative Conference of the United States (ACUS), may arise. Such a court could address disputes related to patent infringement and validity more efficiently[2].

Key Takeaways

  • Innovation in Drug Delivery: The patent introduces a novel system for loading and delivering small volume doses of medication, particularly useful in ocular surgery.
  • Global Protection: The patent has family members in seven countries, ensuring broad protection.
  • Market Impact: The invention can significantly enhance surgical outcomes and patient care in ophthalmology.
  • Legal and Regulatory Framework: The patent is protected under U.S. and international patent laws.
  • Public Access and Integration: Tools like the Global Dossier and Patent Public Search facilitate comprehensive patent searches.

Frequently Asked Questions (FAQs)

Q: What is the main purpose of United States Patent 11,097,061?

A: The main purpose is to provide a system for accurately loading and delivering small volume doses of medication, particularly in ocular surgery.

Q: Who is the assignee of this patent?

A: The assignee is ICON BIOSCIENCE, INC., based in Watertown, MA.

Q: How is the patent protected globally?

A: The patent has eight family members in seven countries, including Australia, Canada, China, and others.

Q: What are the key components of the loading and delivery system?

A: The key components include the syringe delivery ring and the syringe loading guide.

Q: Why is this patent significant in the medical device market?

A: It provides a precise method for delivering small volume doses, enhancing surgical outcomes and patient care in ophthalmology.

Cited Sources

  1. DrugPatentWatch, Patent 11,097,061 - Systems, kits and methods for loading and delivering a small volume dose from a syringe.
  2. Administrative Conference of the United States, U.S. Patent Small Claims Court.
  3. United States Patent and Trademark Office, Patent Claims Research Dataset.
  4. United States Patent and Trademark Office, Search for patents.
  5. United States Code, 35 USC 282: Presumption of validity; defenses.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,097,061

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eyepoint Pharms DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912-001 Feb 9, 2018 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y A METHOD OF LOADING MEDICATION INTO A SYRINGE AND DELIVERING THE MEDICATION TO A TREATMENT SITE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,097,061

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2019218870 ⤷  Subscribe
Canada 3088420 ⤷  Subscribe
China 111757764 ⤷  Subscribe
European Patent Office 3749386 ⤷  Subscribe
Israel 276048 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.